|
|
|
富蘭克林生技領航基金-B/累積
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
26.55 |
-0.47 |
-1.74% |
2019/12/05 |
|
|
| 2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
| 9.54% |
15.99% |
8.18% |
25.28% |
62.03% |
32.92% |
3.61% |
-18.98% |
15.42% |
-17.40% |
| 富蘭克林生技領航基金-B/累積(美元)
基金資料
基金月報
|
|
● 以美國為主 - 美國生技廠商具產品及技術領先優勢且美國為全球最大藥品市場，本基金目前在美國投資比重超過九成 (2013/8月底)。
● 掌握生技技術領導產業 - 大型藥廠與生技公司間進行購併及技術合作的趨勢明確，具研發利基的公司將因而受惠。
● 兼具成長與價值的投資策略 - 採取由下而上的方式，選擇具發展潛力、技術領先且臨床數據及市場發展策略良好的個股進行投資。
● 地利之便，掌握生技產業脈動 - 富蘭克林研究團隊位居加州，緊鄰舊金山生技園區，地利之便能夠掌握生技產業最新脈動。
● 榮獲2012年及2013年Smart智富台灣基金獎(晨星技術指導)「生物科技和健康護理股票型基金獎」，2011年及2012年香港指標雜誌基金大獎「最佳生物科技行業股票基金」
● 晨星基金績效評等四顆星(2013/8月)
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2019/12/05 |
26.55 |
-1.74% |
2019/11/21 |
25.53 |
-0.08% |
| 2019/12/04 |
27.02 |
0.71% |
2019/11/20 |
25.55 |
0.16% |
| 2019/12/03 |
26.83 |
1.51% |
2019/11/19 |
25.51 |
2.24% |
| 2019/12/02 |
26.43 |
-0.64% |
2019/11/18 |
24.95 |
-0.04% |
| 2019/11/29 |
26.60 |
0.23% |
2019/11/15 |
24.96 |
1.79% |
| 2019/11/28 |
26.54 |
0.00% |
2019/11/14 |
24.52 |
-0.53% |
| 2019/11/27 |
26.54 |
0.84% |
2019/11/13 |
24.65 |
0.12% |
| 2019/11/26 |
26.32 |
-0.11% |
2019/11/12 |
24.62 |
-0.69% |
| 2019/11/25 |
26.35 |
2.25% |
2019/11/11 |
24.79 |
-0.24% |
| 2019/11/22 |
25.77 |
0.94% |
2019/11/08 |
24.85 |
2.81% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
-1.74% |
0.04% |
7.71% |
15.59% |
12.88% |
12.55% |
27.40% |
| NBI生技指數 |
-1.40% |
-0.50% |
8.45% |
15.82% |
14.93% |
11.24% |
22.49% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-0.12% |
0.81% |
12.20% |
17.39% |
12.02% |
9.48% |
19.73% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-0.33% |
5.11% |
8.91% |
12.19% |
9.28% |
16.95% |
| MSCI 製藥指數 (price) |
0.00% |
-0.13% |
3.56% |
7.10% |
9.28% |
5.55% |
12.39% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.59% |
6.23% |
16.70% |
19.03% |
10.31% |
15.06% |
|
0.58% |
-0.50% |
3.94% |
10.25% |
12.37% |
10.89% |
17.98% |
|
0.57% |
-0.52% |
3.85% |
9.98% |
11.81% |
9.79% |
16.90% |
|
0.51% |
-0.26% |
9.48% |
15.69% |
18.67% |
10.71% |
29.29% |
|
0.58% |
0.17% |
8.03% |
11.04% |
10.90% |
1.85% |
18.00% |
|
0.74% |
-1.25% |
4.12% |
6.66% |
16.91% |
12.86% |
23.99% |
|
0.97% |
-0.26% |
3.76% |
7.60% |
15.45% |
10.08% |
20.48% |
|
0.78% |
-0.26% |
6.26% |
10.58% |
13.66% |
11.13% |
20.37% |
|
0.68% |
-0.30% |
4.07% |
2.57% |
6.71% |
6.23% |
15.19% |
|
0.70% |
-0.28% |
3.74% |
5.49% |
10.09% |
6.96% |
16.04% |
|
-0.37% |
-2.42% |
-3.10% |
11.95% |
35.10% |
0.00% |
38.95% |
|
0.74% |
-1.11% |
4.49% |
6.00% |
14.34% |
14.14% |
24.02% |
|
-1.73% |
0.09% |
7.83% |
16.00% |
13.64% |
14.02% |
28.97% |
|
0.21% |
0.06% |
5.66% |
10.94% |
15.33% |
11.55% |
24.18% |
|
1.18% |
0.75% |
7.39% |
11.83% |
13.42% |
13.66% |
23.26% |
|
1.18% |
0.72% |
7.29% |
11.53% |
12.84% |
12.51% |
22.11% |
|
1.18% |
0.77% |
7.24% |
11.06% |
11.72% |
9.96% |
19.64% |
|
1.18% |
0.75% |
7.30% |
11.27% |
12.13% |
10.75% |
20.47% |
|
1.18% |
0.77% |
7.47% |
12.02% |
13.83% |
14.51% |
24.13% |
|
0.17% |
-0.44% |
4.54% |
7.74% |
10.06% |
4.97% |
17.47% |
|
0.65% |
0.15% |
9.91% |
16.17% |
14.77% |
8.32% |
25.09% |
|
0.42% |
-0.86% |
10.46% |
15.96% |
17.91% |
14.81% |
32.68% |
|
0.67% |
0.15% |
10.08% |
16.99% |
16.44% |
11.99% |
28.92% |
|
1.03% |
-0.08% |
4.30% |
5.50% |
10.14% |
3.04% |
16.05% |
|
0.81% |
-1.09% |
4.83% |
5.30% |
13.19% |
9.13% |
23.02% |
|
1.06% |
-0.08% |
4.47% |
6.23% |
11.77% |
6.45% |
19.53% |
|
1.51% |
1.46% |
12.06% |
18.62% |
18.64% |
10.60% |
27.93% |
|
-0.09% |
-0.47% |
5.87% |
9.99% |
15.41% |
10.95% |
24.93% |
|
0.56% |
0.37% |
7.54% |
12.68% |
15.81% |
14.59% |
24.60% |
|
0.76% |
0.51% |
7.28% |
14.70% |
16.37% |
14.70% |
24.76% |
| 基金平均績效 |
0.72% |
0.00% |
6.43% |
11.17% |
14.53% |
10.26% |
23.36% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
